Silver: The Undercover Super Metal Does Medicine, Too

Golden Triangle Silver Explorer Acquires Strategic Properties
Source: Streetwise Reports (05/19/2025)

Dolly Varden Silver Corp.'s (DV:TSX.V; DVS:NYSEA; DVQ:FSE) Chief Executive Officer, President, and Director Shawn Khunkhun on Friday is continuing a series of messages to shareholders explaining the company's new direction. One expert notes the company is positioning itself to be the dominant advanced explorer in the Golden Triangle.

read more >

Fortuna Is a Buy After Market Misreads Strong Results
Source: Adrian Day (05/19/2025)

Several gold mining and royalty companies reported first-quarter earnings, with a slew of strong results. For the most part, the stocks responded positively on top of already strong price appreciating, leading Global Analyst Adrian Day to recommend holding rather than buying. There is one exception, however.

read more >

Royalty Company Generates Exceptional Quarter-Over-Quarter Returns
Source: Streetwise Reports (05/19/2025)

Silver Crown Royalties Inc. (SCRI:CBOE; SLCRF:OTCQX; QS0:FSE) reports its eighth consecutive quarter of revenue growth. Read why one expert says the company is "the only pure silver royalty play on the market."

read more >

BC-Based Co. to Buy Four Properties in Golden Triangle
Source: Streetwise Reports (05/19/2025)

Dolly Varden Silver Corp. (DV:TSX.V; DVS:NYSEA; DVQ:FSE) continues delivering on its commitment to make accretive acquisitions. Analysts like this junior mining company; keep reading and find out why.

read more >

Interim Data From TID Trial Are Positive
Source: Streetwise Reports (05/15/2025)

Sernova Biotherapeutics Inc.'s (SVA:TSX.V; SEOVF:OTCQB; PSH:XETRA) regenerative treatment delivered via its Cell Pouch Bio-hybrid Organ is proving to result in insulin independence, among other outcomes. Read what one analyst says are the implications of this clear medical benefit.

read more >